 Alisa Gaskell
Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacterial Proteins | 3 | 2012 | 962 | 0.440 |
Why?
| | Streptomyces coelicolor | 2 | 2012 | 3 | 0.430 |
Why?
| | Iron-Sulfur Proteins | 3 | 2008 | 47 | 0.390 |
Why?
| | Streptomyces | 1 | 2010 | 9 | 0.330 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2012 | 328 | 0.300 |
Why?
| | Peptides | 2 | 2012 | 998 | 0.290 |
Why?
| | Sigma Factor | 1 | 2007 | 43 | 0.260 |
Why?
| | Genes, Bacterial | 1 | 2007 | 166 | 0.250 |
Why?
| | Biological Ontologies | 1 | 2024 | 21 | 0.220 |
Why?
| | Urogenital Abnormalities | 1 | 2025 | 71 | 0.210 |
Why?
| | DNA Copy Number Variations | 1 | 2025 | 183 | 0.210 |
Why?
| | Rare Diseases | 1 | 2024 | 113 | 0.210 |
Why?
| | Developmental Disabilities | 1 | 2025 | 281 | 0.180 |
Why?
| | Brain Stem Neoplasms | 1 | 2023 | 87 | 0.180 |
Why?
| | Burkitt Lymphoma | 1 | 2022 | 62 | 0.170 |
Why?
| | Computational Biology | 1 | 2025 | 681 | 0.160 |
Why?
| | Software | 1 | 2025 | 692 | 0.150 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 293 | 0.140 |
Why?
| | Epilepsy | 1 | 2023 | 387 | 0.140 |
Why?
| | Glioma | 1 | 2023 | 426 | 0.140 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1500 | 0.130 |
Why?
| | Heart Defects, Congenital | 1 | 2025 | 914 | 0.130 |
Why?
| | Transcription Factors | 1 | 2025 | 1742 | 0.130 |
Why?
| | Escherichia coli Proteins | 2 | 2008 | 206 | 0.120 |
Why?
| | Escherichia coli | 3 | 2008 | 855 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 1 | 2023 | 2365 | 0.110 |
Why?
| | Azetidines | 1 | 2014 | 45 | 0.100 |
Why?
| | Transcription, Genetic | 3 | 2008 | 1496 | 0.090 |
Why?
| | Hyphae | 1 | 2012 | 11 | 0.090 |
Why?
| | Piperidines | 1 | 2014 | 217 | 0.090 |
Why?
| | Operon | 1 | 2012 | 69 | 0.090 |
Why?
| | Leukemia | 1 | 2014 | 245 | 0.090 |
Why?
| | Arthropod Proteins | 1 | 2010 | 6 | 0.080 |
Why?
| | Enzyme Precursors | 1 | 2010 | 15 | 0.080 |
Why?
| | Siderophores | 1 | 2010 | 12 | 0.080 |
Why?
| | 4-Butyrolactone | 1 | 2010 | 23 | 0.080 |
Why?
| | Serine Endopeptidases | 1 | 2010 | 128 | 0.080 |
Why?
| | Indoles | 1 | 2014 | 501 | 0.080 |
Why?
| | Sulfonamides | 1 | 2014 | 581 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2010 | 381 | 0.070 |
Why?
| | Trans-Activators | 1 | 2010 | 405 | 0.070 |
Why?
| | Two-Hybrid System Techniques | 1 | 2007 | 59 | 0.070 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2007 | 85 | 0.070 |
Why?
| | beta-Galactosidase | 1 | 2007 | 77 | 0.070 |
Why?
| | Sulfur | 1 | 2008 | 64 | 0.060 |
Why?
| | Melanoma | 1 | 2014 | 761 | 0.060 |
Why?
| | Conserved Sequence | 1 | 2007 | 245 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 396 | 0.060 |
Why?
| | Phenotype | 2 | 2025 | 3164 | 0.060 |
Why?
| | Plasmids | 1 | 2007 | 379 | 0.060 |
Why?
| | Cysteine | 1 | 2007 | 210 | 0.060 |
Why?
| | Facies | 1 | 2025 | 22 | 0.060 |
Why?
| | Failure to Thrive | 1 | 2025 | 28 | 0.060 |
Why?
| | Ectodermal Dysplasia | 1 | 2025 | 19 | 0.060 |
Why?
| | Iron | 1 | 2008 | 359 | 0.060 |
Why?
| | Haploinsufficiency | 1 | 2025 | 55 | 0.060 |
Why?
| | Adenosine Triphosphate | 1 | 2007 | 498 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1958 | 0.050 |
Why?
| | Whole Genome Sequencing | 1 | 2025 | 183 | 0.050 |
Why?
| | Abnormalities, Multiple | 1 | 2025 | 197 | 0.050 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2157 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2024 | 521 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 2023 | 39 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2931 | 0.050 |
Why?
| | Cytidine Deaminase | 1 | 2023 | 59 | 0.050 |
Why?
| | Genome, Human | 1 | 2025 | 422 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2197 | 0.050 |
Why?
| | Brain Stem | 1 | 2023 | 96 | 0.050 |
Why?
| | Gene Fusion | 1 | 2022 | 29 | 0.050 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2025 | 550 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2022 | 322 | 0.040 |
Why?
| | Genetic Testing | 1 | 2023 | 482 | 0.040 |
Why?
| | Adolescent | 3 | 2025 | 22453 | 0.040 |
Why?
| | Child | 3 | 2025 | 22657 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 477 | 0.040 |
Why?
| | Child, Preschool | 2 | 2025 | 11799 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2022 | 1718 | 0.030 |
Why?
| | Humans | 7 | 2025 | 144957 | 0.030 |
Why?
| | Signal Transduction | 1 | 2010 | 5233 | 0.030 |
Why?
| | Oxidation-Reduction | 2 | 2008 | 1087 | 0.030 |
Why?
| | GTP Phosphohydrolases | 1 | 2014 | 93 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 2014 | 164 | 0.020 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2014 | 82 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2014 | 311 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2014 | 783 | 0.020 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2014 | 226 | 0.020 |
Why?
| | Infant | 1 | 2025 | 10039 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2008 | 369 | 0.020 |
Why?
| | Chelating Agents | 1 | 2008 | 73 | 0.020 |
Why?
| | Electrons | 1 | 2008 | 88 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2014 | 1167 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2014 | 2499 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3550 | 0.010 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2008 | 346 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2008 | 862 | 0.010 |
Why?
| | Young Adult | 1 | 2022 | 14126 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2023 | 17101 | 0.010 |
Why?
| | Oxygen | 1 | 2008 | 995 | 0.010 |
Why?
| | Male | 2 | 2025 | 72406 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 4099 | 0.010 |
Why?
| | Models, Molecular | 1 | 2008 | 1619 | 0.010 |
Why?
| | Adult | 1 | 2025 | 40506 | 0.010 |
Why?
| | Female | 1 | 2025 | 78376 | 0.010 |
Why?
| | Aged | 1 | 2014 | 25947 | 0.010 |
Why?
|
|
Gaskell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|